Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Date of authorisation: 24/08/2017, Revision: 25, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 February 2026 - 11:00

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Date of authorisation: 24/08/2017, Revision: 25, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/imraldi

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters